Dive into how we’re rethinking drug discovery through the lens of transcription factor biology in a new article featured on the front page of Drug Target Review

Scripta announces a successful $12 million seed funding, a novel biology-first, transcription-factor-centered approach to drug discovery, and appointment of Ray Barlow as Non-Executive Director.

We are hiring a Research Scientist to join our growing, multi-disciplinary team to drive development of novel cell assays and shape the next wave of scientific progress.

Hear from our founder & CEO, Peter Hamley, on the latest episode of Careers in Discovery.

Why starting from the master regulators of biology uncovers drug opportunities that the literature misses

Scripta is on the look out for a new Bioinformatician to join the team.